Figure 1.
Cancer-specific death after diagnosis by age and PSA at diagnosis. For all men aged 50–59 years (a), 60–69 years (b), 70–79 years (c), and 80–89 years (d) diagnosed with prostate cancer, cancer-specific death risk is plotted as a function of time elapsed from diagnosis (years) for various ranges of prostate-specific antigen (PSA) levels at diagnosis.